A61K 38/043
Kallidins
Official title: {Kallidins; Bradykinins; Related peptides}
A61K38/043 (Kallidins) appears on 60 US grants and 77 published applications in this corpus.
Search patents in A61K- Granted patents
- 60
- Published applications
- 77
- Assignees
- 53
- Inventors
- 161
- Latest grant
- 22 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 3 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 3 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 5 | 1 |
| 2002 | 1 | 2 |
| 2003 | 1 | 6 |
| 2004 | 0 | 2 |
| 2005 | 1 | 3 |
| 2006 | 0 | 4 |
| 2007 | 3 | 2 |
| 2008 | 0 | 5 |
| 2009 | 3 | 8 |
| 2010 | 0 | 4 |
| 2011 | 2 | 4 |
| 2012 | 7 | 3 |
| 2013 | 4 | 5 |
| 2014 | 1 | 3 |
| 2015 | 3 | 3 |
| 2016 | 3 | 3 |
| 2017 | 0 | 5 |
| 2018 | 1 | 1 |
| 2019 | 0 | 2 |
| 2020 | 0 | 2 |
| 2021 | 0 | 2 |
| 2022 | 2 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 3 |
| 2025 | 1 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Utilizing the innate immune system to deliver therapeutic agents22 Apr 2025US 12,280,016 B2Drexel University
- Pharmaceutical composition comprising tryptophan and phyllokinin derivative for use in treating psychiatric and psychological conditions15 Aug 2023US 11,723,945 B2
- Adhesion prevention material1 Nov 2022US 11,484,564 B2Otsuka Pharmaceutical Factory, Inc.
- Kinin-based theranostic probes for solid cancers and uses thereof4 Jan 2022US 11,213,597 B2SociéTé De Commercialisation Des Produits De La Recherche AppliquéE Socpra Sciences Santé Et Humaines S.E.C.
- Compositions targeting bradykinin receptor B1 for medical imaging of cancer and other disorders7 Aug 2018US 10,039,846 B2British Columbia Cancer Agency Branch
- Pharmaceutical composition comprising tryptophan and phyllokinin derivative for use in treating psychiatric and psychological conditions28 May 2026US 2026/0144842 A1Temple Otorongo LLC
- Utilizing the innate immune system to deliver therapeutic agents2 Oct 2025US 2025/0302749 A1Drexel University
- Use of kinin or derivative thereof in treating vci, psci, or csvd17 Apr 2025US 2025/0122257 A1Zonhon Biopharma Institute Inc.
- Application of Inhibitors Targeting CD226 Molecules in Anti-Tumor Metastasis13 Jun 2024US 2024/0189383 A1Air Force Medical University
- Prolyl hydroxylase domain inhibitor treatment to improve survivability of hemorrhagic shock18 Apr 2024US 2024/0122987 A1
Most cited
By later US patents
- Increasing blood-brain barrier permeability with permeabilizer peptides176US 5,268,164 AAlkermes, Inc. · 1993
- Urologic irrigation solution and method for inhibition of pain, inflammation and spasm152US 5,858,017 AOmeros Medical Systems, Inc. · 1999
- Increasing blood-brain barrier permeability with permeabilizer peptides149US 5,506,206 AAlkermes, Inc. · 1996
- Arthroscopic irrigation solution and method for inhibition of pain and inflammation140US 5,860,950 AOmeros Medical Systems, Inc. · 1999
- Method for increasing blood-brain barrier permeability by administering a bradykinin agonist of blood-brain barrier permeability130US 5,112,596 AAlkermes, Inc. · 1992